References
- Morishita K, Parker D S, Mucenski M L, Jenkins N A, Copeland N G, Ihle J N. Retroviral activation of a novel gene encoding a zinc finger protein in IL-3-dependent myeloid leukemia cell lines. Cell 1988; 54: 831–840
- Mucenski M L, Taylor B A, Ihle J N, Hartley J W, Morse H C, III, Jenkins N A, Copeland N G. Identification of a common ecotropic viral integration site, Evi-1, in the DNA of AKXD murine myeloid tumors. Mol Cell Biol 1988; 8: 301–308
- Morishita K, Parganas E, William C L, Whittaker M H, Drabkin H, Oval J, et al. Activation of EVI1 gene expression in human acute myelogenous leukemias by translocations spanning 300 – 400 kilobases on chromosome band 3q26. Proc Natl Acad Sci USA 1992; 89: 3937–3941
- Fichelson S, Dreyfus F, Berger R, Melle J, Bastard C, Miclea J M, et al. Evi-1 expression in leukemic patients with rearrangements of the 3q25-q28 chromosomal region. Leukemia 1992; 6: 93–99
- Nucifora G, Begy C R, Kobayashi H, Roulston D, Claxton D, Pedersen-Bjergaard J, et al. Consistent intergenic splicing and production of multiple transcripts between AML1 at 21q22 and unrelated genes at 3q26 in (3;21)(q26;q22) translocations. Proc Natl Acad Sci USA 1994; 91: 4004–4008
- Levy E R, Parganas E, Morishita K, Fichelson S, James L, Oscier D, et al. DNA rearrangements proximal to the EVI1 locus associated with the 3q21q26 syndrome. Blood 1994; 83: 1348–1354
- Bitter M A, Neilly M E, Le Beau M M, Pearson M G, Rowley J D. Rearrangements of chromosome 3 involving bands 3q21 and 3q26 are associated with normal or elevated platelet counts in acute nonlymphocytic leukemia. Blood 1985; 66: 1362–1370
- Grigg A P, Gascoyne R D, Phillips G L, Horsman D E. Clinical, haematological and cytogenetic features in 24 patients with structural rearrangements of the Q arm of chromosome 3. Br J Haematol 1993; 83: 158–165
- Jotterand Bellomo M, Parlier V, Muhlematter D, Grob J P, Beris P. Three new cases of chromosome 3 rearrangement in bands q21 and q26 with abnormal thrombopoiesis bring further evidence to the existence of a 3q21q26 syndrome. Cancer Genet Cytogenet 1992; 59: 138–160
- Reiter E, Greinix H, Rabitsch W, Keil F, Schwarzinger I, Jaeger U, et al. Low curative potential of bone marrow transplantation for highly aggressive acute myelogenous leukemia with inversioin inv(3)(q21q26) or homologous translocation t(3;3)(q21;q26). Ann Hematol 2000; 79: 374–377
- Testoni N, Borsaru G, Martinelli G, Carboni C, Ruggeri D, Ottaviani E, et al. 3q21 and 3q26 cytogenetic abnormalities in acute myeloblastic leukemia: biological and clinical features. Haematologica 1999; 84: 690–694
- Johansson B, Fioretos T, Mitelman F. Cytogenetic and molecular genetic evolution of chronic myeloid leukemia. Acta Haematol 2002; 107: 76–94
- van Waalwijk B, van Doorn-Khosrovani S, Erpelinck C, van Putten W L, Valk P J, et al. High EVI1 expression predicts poor survival in acute myeloid leukemia: a study of 319 de novo AML patients. Blood 2003; 101: 837–845
- Russell M, List A, Greenberg P, Woodward S, Glinsmann B, Parganas E, et al. Expression of EVI1 in myelodysplastic syndromes and other hematologic malignancies without 3q26 translocations. Blood 1994; 84: 1243–1248
- Nucifora G, Laricchia-Robbio L, Senyuk V. EVI1 and hematopoietic disorders: history and perspectives. Gene 2006; 368: 1–11
- Huang S. Histone methyltransferases, diet nutrients and tumour suppressors. Nat Rev Cancer 2002; 2: 469–476
- Weisser M, Kern W, Schoch C, Tschulik C, Hiddemann W, Haferlach T, et al. Reverse transcriptase-polymerase chain reaction based quantification of the combined MDS-EVI1/EVI1 gene in acute myeloid leukemia. Leuk Lymphoma 2006; 47: 2646–2648